RxDoctor Payments Data

Michael Ard, MD

Family Medicine · Louisville, MSNPI 1962484899

Payments from drug & device makers

$1,872in general payments, 2019–2025

Across 121 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$619
  • Novo Nordisk$243
  • Lilly USA, LLC$186
  • Johnson & Johnson$143
  • Amgen$130
  • E.r. Squibb & Sons, L.L.C.$96
  • plus $453 from 12 others

What the payments were for

  • Food & beverage$1,872100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,872 in reported general payments places this provider in the 65th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$41,579
Medicare patients
141
Services billed
477

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine18$155,027
OzempicSemaglutide113$113,652
EliquisApixaban209$87,731
TrulicityDulaglutide31$38,709
FarxigaDapagliflozin Propanediol59$28,812
Bydureon BciseExenatide Microspheres29$23,134
JardianceEmpagliflozin40$21,077
Combivent RespimatIpratropium/Albuterol Sulfate34$16,747
XareltoRivaroxaban46$15,276
Repatha SureclickEvolocumab19$14,417
Breo ElliptaFluticasone/Vilanterol21$11,806
MyrbetriqMirabegron23$10,011
Daptomycin12$9,378
Xigduo XrDapaglifloz Propaned/Metformin14$8,466
Tresiba Flextouch U-100Insulin Degludec17$7,845

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$52$155,02718 claims
Novo NordiskOzempic$243$113,652113 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$619$41,62591 claims
Lilly USA, LLCTrulicity$186$38,70931 claims
Boehringer IngelheimJardiance, Combivent Respimat$44$37,82474 claims
Johnson & JohnsonXarelto$143$15,27646 claims
GSKBreo Ellipta, Arexvy$14$15,11732 claims
Astellas Pharma US IncMyrbetriq$72$10,01123 claims
AbbVieSynthroid$56$3,52869 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Louisville

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →